Miyoshi Hirata

Title: Miyoshi Hirata: Innovator in Quantitative Analysis

Introduction

Miyoshi Hirata is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of quantitative analysis, particularly in the area of steroid analysis. With a total of 6 patents to her name, her work has had a substantial impact on medical testing and diagnostics.

Latest Patents

Hirata's latest patents include a method and reagent for the quantitative analysis of 3-oxo-5.beta.-steroid. This innovative method involves the action of 3-oxo-5.beta.-steroid.DELTA..sup.4 -dehydrogenase on a sample in the presence of a reducing chromophoric agent, allowing for the measurement of the optical density of the resulting chromophoric substance. A typical reducing chromophoric agent used in this process is a tetrazolium compound. This invention provides a simple and reliable method for liver function tests. Another notable patent focuses on the quantitative analysis of 3.alpha.-hydroxysteroid, which can be achieved by utilizing 3.alpha.-hydroxysteroid dehydrogenase in conjunction with nicotinamide adenine dinucleotide and tetrazolium compounds. This method allows for accurate analysis of the resultant formazan.

Career Highlights

Miyoshi Hirata is currently employed at Daiichi Pure Chemicals Co., Ltd., where she continues to advance her research and development efforts. Her work has been instrumental in enhancing the reliability and efficiency of medical testing methods.

Collaborations

Hirata has collaborated with notable colleagues such as Nobuyoshi Ebata and Koji Ushizawa, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Miyoshi Hirata's contributions to quantitative analysis and her innovative patents have established her as a key figure in her field. Her work continues to influence medical diagnostics and improve testing methodologies.